Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer ACCESS Newswire·Sunshine Biopharma Inc.

Revenue: US$9.29m (up 69% from FY 2023). Net loss: US$40.7m (loss narrowed by 20% from FY 2023). US$0.72 loss per share (improved from US$1.11 loss in FY 2023). We've found 21 US stocks that are ...

NEW YORK CITY, NY / ACCESS Newswire / April 5, 2025 / WHY: New York, N.Y., April 5, 2025. Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities ...

Alcohol Detoxification and Anti-Hangover Beverage (Available on amazon.com and unbuzzd.com) to be Distributed by FUSION in Puerto Rico and Caribbean Region TORONTO, April 03, 2025 (GLOBE NEWSWIRE ...

On Tuesday, Bernstein released a report detailing the complexities of tariff risks within the biopharma sector and its potential impact on major companies. The analysis aims to unravel the ...

BioPharma Credit (LSE: BPCR) is one of the more esoteric investment trusts listed in London. Biotech is a specialist sector that I usually wouldn’t touch with a barge pole. The risk of failure ...

The drumbeat of AI advancements over the last year has left us all breathless, wondering which benchmark will be broken next and which new problems we can solve in biology. But the promise of AI ...

Nintendo announced that its Switch 2 Joy-Cons could be used as a mouse — in either hand, even — during its Switch 2 Direct on April 2. Mice and other pointers have been aiding in making ...

Life-changing interventions that have previously been pipedreams are now within reach for the biopharma industry, made possible through an increasingly sophisticated understanding of human biology ...

Equities research analysts at Redburn Atlantic began coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) in a research note issued on Monday, Marketbeat.com reports.

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...